{
    "2019-09-19": [
        [
            {
                "time": "",
                "original_text": "拟折价7%配股，最高净筹40亿港元，国药控股究竟缺的是啥？",
                "features": {
                    "keywords": [
                        "国药控股",
                        "配股",
                        "折价",
                        "40亿港元"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}